Concepedia

Publication | Closed Access

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

DOI

762

Citations

18

References

2003

Year

John C. Davis, Désirée van der Heijde, Jürgen Braun, Maxime Dougados, John J. Cush, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert D. Inman, Wayne Tsuji
Arthritis & Rheumatism

Abstract

Etanercept is a highly effective and well tolerated treatment in patients with active AS.

References

YearCitations

Page 1